Evidence map›Paper›PMID 27926930›Full record

ArticlePLoS pathogens2016

Cytomegalovirus-Specific IL-10-Producing CD4+ T Cells Are Governed by Type-I IFN-Induced IL-27 and Promote Virus Persistence.

Mathew Clement, Morgan Marsden, Maria A Stacey, Juneid Abdul-Karim, Silvia Gimeno Brias, Diana Costa Bento, Martin J Scurr, Peter Ghazal, Casey T Weaver, Gianluca Carlesso and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. The immune response to human cytomegalovirus: impact of age, co-morbidities and the significance of anti-viral activity assessment.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  5. Article
  6. Review
  7. Immune surveillance of cytomegalovirus in tissues.Cellular & molecular immunology · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. IL-10-Secreting CD8Pathogens (Basel, Switzerland) · 2022
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Mathew ClementDivision of Infection & Immunity, Cardiff University, Cardiff, United Kingdom.ORCID http://orcid.org/0000-0002-9280-5281
Morgan MarsdenDivision of Infection & Immunity, Cardiff University, Cardiff, United Kingdom.
Maria A StaceyDivision of Infection & Immunity, Cardiff University, Cardiff, United Kingdom.
Juneid Abdul-KarimDivision of Infection & Immunity, Cardiff University, Cardiff, United Kingdom.
Silvia Gimeno BriasDivision of Infection & Immunity, Cardiff University, Cardiff, United Kingdom.
Diana Costa BentoDivision of Infection & Immunity, Cardiff University, Cardiff, United Kingdom.
Martin J ScurrDivision of Infection & Immunity, Cardiff University, Cardiff, United Kingdom.ORCID http://orcid.org/0000-0002-4120-0688
Peter GhazalDivision of Infection and Pathway Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Casey T WeaverDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Gianluca CarlessoRespiratory, Inflammation and Autoimmunity, Research Department, MedImmune LLC, Gaithersburg, MD, United States of America.
Simon ClareWellcome Trust Sanger Institute, Cambridgeshire, United Kingdom.
Simon A JonesDivision of Infection & Immunity, Cardiff University, Cardiff, United Kingdom.ORCID http://orcid.org/0000-0001-7297-9711
Andrew GodkinDivision of Infection & Immunity, Cardiff University, Cardiff, United Kingdom.
Gareth W JonesDivision of Infection & Immunity, Cardiff University, Cardiff, United Kingdom.
Ian R HumphreysDivision of Infection & Immunity, Cardiff University, Cardiff, United Kingdom.
Cardiff University · GBWellcome Sanger Institute · GBUniversity of Alabama at Birmingham · USUniversity of Edinburgh · GB

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
Arthritis Research UK 20770NCI NIH HHS P30 CA013148Versus Arthritis 20305Wellcome Trust
6 · The paper itself

Abstract

CD4+ T cells support host defence against herpesviruses and other viral pathogens. We identified that CD4+ T cells from systemic and mucosal tissues of hosts infected with the β-herpesviridae human cytomegalovirus (HCMV) or murine cytomegalovirus (MCMV) express the regulatory cytokine interleukin (IL)-10. IL-10+CD4+ T cells co-expressed TH1-associated transcription factors and chemokine receptors. Mice lacking T cell-derived IL-10 elicited enhanced antiviral T cell responses and restricted MCMV persistence in salivary glands and secretion in saliva. Thus, IL-10+CD4+ T cells suppress antiviral immune responses against CMV. Expansion of this T-cell population in the periphery was promoted by IL-27 whereas mucosal IL-10+ T cell responses were ICOS-dependent. Infected Il27rα-deficient mice with reduced peripheral IL-10+CD4+ T cell accumulation displayed robust T cell responses and restricted MCMV persistence and shedding. Temporal inhibition experiments revealed that IL-27R signaling during initial infection was required for the suppression of T cell immunity and control of virus shedding during MCMV persistence. IL-27 production was promoted by type-I IFN, suggesting that β-herpesviridae exploit the immune-regulatory properties of this antiviral pathway to establish chronicity. Further, our data reveal that cytokine signaling events during initial infection profoundly influence virus chronicity.

Indexed as

AnimalsCD4-Positive T-LymphocytesCytomegalovirusCytomegalovirus InfectionsDisease Models, AnimalHumansInterferon Type IInterleukin-10Interleukin-27MiceMice, Inbred C57BLMice, KnockoutInterferon Type IInterleukin-10Interleukin-27

Identifiers

PMID27926930
PMCPMC5142785
OpenAlexW2560329801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.